|
Investigation: visual inspection: particles (calcified deposits) are visible of the part of catheter and in the inlet spout, some particles are in the delivery liquid observed trough the visual inspection.Permeability test: a permeability test has shown that the valve is permeable.Adjustment test: this is a fixed pressure valve.An adjustment test is not applicable.Braking force and brake function test: this is a fixed pressure valve.A braking force and brake function tests are not applicable.Computer controlled test: to investigate the claim of overdrainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in both the horizontal as well as the vertical positions.The results show that the valve is operating within the accepted tolerance in the vertical but not in the horizontal position.The test showed a decreased flow of liquid.Results: first, we performed a visual inspection of the paedigav.Some particles, proteins or other tissue residues are visible on the product, but no defects or other abnormalities.Next, we tested the permeability of the valve.The valve was shown to be permeable.Then we carried out a computer controlled simulated flow test.The measured opening pressure was within the accepted tolerance in the vertical position but not in the horizontal position.The opening pressure was significantly lower than expected and showed a decreased flow of liquid.Finally, we have dismantled the valve.Inside the valve we have found a build-up of substances (likely protein).Based on our investigation, we are unable to substantiate the clinical claim of overdrainage.At the time of our investigation, the valve was operating within the specified tolerances in the vertical position.We observed that the valve shows a slower flow of liquid in the horizontal position, likely due to the deposits observed inside the valve.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.However, it is possible that the deposits observed inside the valve could have caused the malfunction in the past.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke (b)(4).No further regulatory actions are required from our point of view.
|